Ocena stężeń wybranych czynników proangiogennych a nowotworzenie w grupie chorych leczonych nerkozastępczo

• Authors: Doskocz Krzysztof , Sapilak Bartosz , Steciwko Andrzej , Grzanka Magdalena , Borowiec Tomasz , Filipczyk-Cisarz Emilia
• Languages of publication: PL

Keywords

PL

angiopoetyna-1, angiopoetyna-2, angiogeneza, hemodializa, nowotworzenie.

• Publisher: Stowarzyszenie Przyjaciół Medycyny Rodzinnej i Lekarzy Rodzinnych
• Journal: Family Medicine & Primary Care Review
• Year: 2011
• Issue: 1
• Pages: 16-22

Contributors

author

Doskocz Krzysztof

author

Sapilak Bartosz

author

Steciwko Andrzej

author

Grzanka Magdalena

author

Borowiec Tomasz

author

Filipczyk-Cisarz Emilia

References

• Maisonneuve P, Agodoa L, Gellert R, et al. Cancer in patients on dialysis for endstage renal disease: an international collaborative study. Lancet 1999; 354: 93–99.
• Książek A, Rutkowski B. Nefrologia. Wyd. 1. Lublin: Wydawnictwo Czelej; 2004.
• Kasiske BL, Snyder JJ , Gilbertson DT, et al. Cancer after kidney transplantation in the United States. Am J Transplant 2004; 4: 905–913.
• Folkman J. Tumor angiogenesis therapeutic implications. N Engl J Med 1971; 285: 1182–1186.
• Sato TN, Tozawa Y, Teutsch U, et al. Distinct roles of the receptor tyrosine kinases: Tie-1 and Tie-2 in blood vessel formation. Nature 1995; 376: 70–74.
• De Palma M, Venneri M, Galli R, et al. Tie-2 identifies a hematopoietic lineage of proangiogenic monocytes required for tumor vessel formation and mesenchymal population of pericyte progenitors. Cancer Cell 2005; 8: 211–216.
• Davis S, Aldrich TH, Jones PF, et al. Isolation of angiopoietin-l, a ligand for the TIE2 receptor, by secretion-trap expression cloning. Cell 1996; 87: 1161–1169.
• Huang YQ, Li JJ , Karpatkin S. Identification of a family of alternatively spliced mRNA species of angiopoietin-1. Blood 2000; 95(6): 1993–1999.
• Kim KT, Choi HH, Steinmetz MO, et al. Oligomerization and multimerization are critical for angiopoietin-1 to bind and phosphorylate Tie2. J Biol Chem 2005; 280: 20126–20131.
• Maisonpierre PC, Suri C, Jones PF, et al. Angiopoietin-2, a natural antagonist for Tie2 that disrupts in vivo angiogenesis.Science 1997; 277: 55–60.
• Yamakawa M, Liu LX, Date T, et al. Hypoxia-inducible factor-l mediates activation of cultured vascular endothelial cells by inducing multiple angiogenic factors. Circ Res 2003; 93: 664–674.
• Xu Y, Yu Q. Angiopoietin-1, unlike angiopoietin-2, is incorporated into the extracellular matrix via its linker peptide region. J Biol Chem 2001; 276(37): 34990–34998.
• Fiedler U, Krissl T, Koidl S, et al. Angiopoietinl and angiopoietin2 share the same binding domains in the Tie-2 receptor involving thc first Ig-like loop and the epidermal growth factor-like repeats. J Biol Chem 2003; 278: 1721–1727.
• L oughna S, Sato TN. Angiopoietin and Tie signaling pathways in vascular development. Matrix Biol 2001; 20: 319––325.
• Suri C, Jones PF, Patan S, et al. Requisite role of angiopoietin-1, a ligand for the TIE2 receptor, during embryonic angiogenesis.Cell 1996; 87: 1171–1180.
• Harfouche R, Hussain SN. Signaling and regulation of endothelial cell survival by angiopoietin-2. Am J Physiol Heart Circ Physiol 2006; 291: 635–645.
• Yu Q, Stamenkovic I. Angiopoietin-2 is implikated in the regulation of tumor angiogenesis. Am J Pathol 2001; 563––570.
• Vajkoczy P, Farhadi M, Gaumann A, et al. Microtumor growth initiates angiogenic sprouting with simultaneous expressionof VEGF, VEGF receptor-2, and angiopoietin-2. J Clin Invest 2002; 109: 777–785.
• Shim WS, Teh M, Bapna A, et al. Angiopoietin l promotes tumor angiogenesis and tumor vessel plasticity of human cervical cancer in mice. Exp Cell Res 2002; 279: 299–309.
• Stoeltzing O, Ahmad SA, Liu W, et al. Angiopoietin-1 inhibits vascular permeability, angiogenesis, and growth of hepatic colon cancer tumors. Cancer Res 2003; 63: 3370–3377.
• Cao Y, Sonveaux P, Liu S, et al. Systemic overexpression of angiopoietin-2 promotes tumor microvessel regression and inhibits angiogenesis and tumor growth. Cancer Res 2007; 67: 3835–3844.
• Giuliano JS Jr, Lahni PM, Bigham MT, et al. Plasma angiopoietin-2 levels increase in children following cardiopulmonary bypass. Intensive Care Med 2008; 34(10): 1851–1857.
• David S, Kümpers P, Lukasz A, et al. Circulating angiopoietin-2 levels increase with progress of chronic kidney disease Nephrol Dial Transplant 2010; 25(8): 2571–2576..
• David S, Kümpers P, Hellpap J, et al. Angiopoietin 2 and cardiovascular disease in dialysis and kidney transplantation.Am J Kidney Dis 2009; 53(5): 770–778.